David Lebwohl

Inquirer
DISC Type : cd

Chief Medical Officer at Intellia Therapeutics, Inc.

Madison, New Jersey, United States

Overview

Dr. David Lebwohl is the Chief Medical Officer at Intellia Therapeutics, leveraging his extensive background in oncology and novel therapeutics. A graduate of Harvard and Yale School of Medicine, he previously held senior roles at Novartis, where he led the development of the pioneering CAR-T cell therapy, Kymriah.

He has a significant track record of leading teams in the development of groundbreaking treatments, from his time at Semma Therapeutics (acquired by Vertex) to his current focus on CRISPR-based medicines at Intellia.

Personality Overview

Judgemental

Demanding

ROI Conscious

They can be nudged to make faster decisions by offering what they value.  They focus on objectivity in a pitch and pay little attention to bells and whistles. They respond well to confident salespeople.

Topics They Care About

CRISPR Therapeutics
As CMO of Intellia, he actively leads and discusses the clinical advancement of CRISPR-based treatments for genetic diseases like ATTR amyloidosis and Hereditary Angioedema (HAE).
Cell & Gene Therapy
He has deep expertise in this area, having led the global program for Kymriah (CTL019), one of the first approved CAR-T cell therapies, during his tenure at Novartis.
Oncology Development
Before focusing on gene editing, he served as the Global Head of Oncology Clinical Development at Novartis, overseeing numerous cancer therapy programs.

Media Appearances

David has no verified media appearances

Work History

4-2020
Chief Medical Officer at Intellia Therapeutics, Inc.
11-2018 - 4-2020
Chief Medical Officer at Semma Therapeutics
9-2016 - 11-2018
Senior VP and Exec. Global Program Head, CART Global Program Team at Novartis
3-2015 - 8-2016
Senior VP and Exec. Global Program Head, CTL019, Cell and Gene Therapies Unit, Novartis at Novartis
5-2013 - 3-2015
Sr. VP and Global Head, Oncology Clinical Development at Novartis

Education

1977 - 1981
Doctor of Medicine (MD) from Yale School of Medicine
AB from Harvard University

More Information

Social Presence :

Prographics :

Exp : 12 Location : Madison, New Jersey, United States Job Level : Leadership Designation : Chief Medical Officer at Intellia Therapeutics, Inc.
URL has been copied!

Insights For Selling To David

During A Call Or A Meeting

DO's

  • Highlight the competitive differentiation of your product
  • Make sure that you you respond to any queries from them quickly
  • Make sure that they have the necessary authority, they could present false stature sometimes

DONT's

  • Do not give up if they are not convinced, try again with a different approach
  • Refrain from asking too many questions
  • Don’t try to be an alpha salesperson, give them equal space

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with David is

  • Conviction in the product matters to them, followed by proof points and strong testimonials.
  • Will you ever get a clear answer from David

  • They may not be very forthcoming, but they will say no if needed.

Insights For Deal Planning

    How fast (or slow) will David move?

  • They are neither the fastest decision makers nor the slowest.
  • Can David take some risk or not?

  • They can take risks but after weighing up the pros and cons.

You And David

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.